Wall Street RegretsThe regret calculator.

What if you'd held BGLC?

A $1,000 investment in BioNexus Gene Lab Corp (BGLC) at the month-end close of 2021-01 would be worth $5.69 at the close of 2026-08 — -99.4% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,075.

$1,000 since 2021$5.69Total return-99.4%Multiple0.01×CAGR-60.4%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$5.69Gain+$-994 (-99.4%)Multiple0.0×CAGR-60.4%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2021$5.692022$6.142023$13.772024$2962025$5612026$397

    Every year, $1,000 from 2021

    YearValue of $1,000Year return
    2021$1,000
    2022$446-55.4%
    2023$20.74-95.4%
    2024$10.95-47.2%
    2025$15.45+41.1%
    2026$6.14-60.3%

    Best and worst month-end to buy

    The best single month-end close to have bought BGLC was 2026-07 ($1.32): $1,000 then is $1,189 today. The worst was 2021-01 ($276): $1,000 then is $5.69.

    FAQ

    What would $1,000 in BGLC be worth today?

    A $1,000 investment in BioNexus Gene Lab Corp (BGLC) at the start of 2021 would be worth about $5.69 today, a total return of -99.4%. Dividends are reinvested in these figures.

    What were the best and worst years for BGLC?

    BioNexus Gene Lab Corp (BGLC)'s strongest calendar year since 2021 was 2025, a +41.1% return — $1,000 held through that year became about $1,411 by year-end. Its weakest year was 2023, at -95.4%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in BGLC have grown?

    Investing $100 at the end of every month since 2021-01 would have grown to about $1,722 on $6,800 invested.

    Did BGLC beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $2,075. BGLC trailed the S&P 500 by +99.7% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    BioNexus Gene Lab Corp (BGLC) historical total-return data from 2021-01 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.